AJP - Heart BIOPAC complete lab solutions
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 285: H2034-H2038, 2003. First published July 17, 2003; doi:10.1152/ajpheart.00324.2003
0363-6135/03 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
285/5/H2034    most recent
00324.2003v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (11)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bruck, H.
Right arrow Articles by Brodde, O.-E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bruck, H.
Right arrow Articles by Brodde, O.-E.

Thr164Ile polymorphism of the human {beta}2-adrenoceptor exhibits blunted desensitization of cardiac functional responses in vivo

Heike Bruck,1,2 Kirsten Leineweber,1,2 Anke Ulrich,3 Joachim Radke,3 Gerd Heusch,1 Thomas Philipp,1 and Otto-Erich Brodde1,2

1Departments of Pathophysiology and Nephrology, University of Essen Medical School, D-45147 Essen; and 2Institute of Pharmacology and 3Department of Anesthesiology, Martin-Luther-University of Halle, D-06097 Halle, Germany

Submitted 10 April 2003 ; accepted in final form 8 July 2003

In subjects heterozygous for Thr164Ile {beta}2-adrenoceptor ({beta}2AR) polymorphism, cardiac responses to {beta}2AR agonist stimulation are blunted. In this study, we investigated agonist-induced desensitization of Thr164Ile {beta}2ARs. For this purpose, we assessed in six subjects with heterozygous Thr164Ile {beta}2ARs and in 10 subjects with homozygous wild-type (WT) {beta}2ARs the effects of 2-wk oral treatment with 3 x 5 mg/day terbutaline on terbutaline infusion-induced increases in heart rate (HR) and contractility [measured as shortening of HR-corrected duration of electromechanical systole (QS2c)]. Compared with WT {beta}2AR subjects, Thr164Ile subjects exhibited a blunted terbutaline-induced maximum increase in HR (WT 32 ± 4 beats/min, Thr164Ile 19 ± 3 beats/min, P < 0.05) and contractility (WT –54 ± 2 ms, Thr164Ile –37 ± 6 ms, P < 0.05). Two-week oral terbutaline treatment desensitized cardiac {beta}2AR responses to terbutaline infusion (increase in HR: WT 10 ± 2 beats/min, Thr164Ile 8 ± 4 beats/min; increase in contractility: WT –22 ± 5 ms Thr164Ile: –17 ± 6 ms); however, the extent of desensitization was larger in WT than Thr164Ile {beta}2AR subjects. Thus, after 2-wk oral terbutaline treatment cardiac, {beta}2AR responses did not differ anymore between WT and Thr164Ile {beta}2AR subjects. We conclude that agonist-induced desensitization of cardiac {beta}2ARs is more pronounced in WT than Thr164Ile subjects. Thus cardiac Thr164Ile subjects appear to be somewhat protected against agonist-induced desensitization.

genetic polymorphism; heart rate; contractility



Address for reprint requests and other correspondence: O.-E. Brodde, Depts. of Pathophysiology and Nephrology, Univ. of Essen Medical School, Hufelandstrasse 55, D-45147 Essen, Germany (E-mail: otto-erich.brodde{at}uni-essen.de).




This article has been cited by other articles:


Home page
Pharmacol. Rev.Home page
D. Rosskopf and M. C. Michel
Pharmacogenomics of G Protein-Coupled Receptor Ligands in Cardiovascular Medicine
Pharmacol. Rev., December 1, 2008; 60(4): 513 - 535.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
E. Barbato, M. Penicka, L. Delrue, F. Van Durme, B. De Bruyne, M. Goethals, W. Wijns, M. Vanderheyden, and J. Bartunek
Thr164Ile polymorphism of {beta}2-adrenergic receptor negatively modulates cardiac contractility: implications for prognosis in patients with idiopathic dilated cardiomyopathy
Heart, July 1, 2007; 93(7): 856 - 861.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2003 by the American Physiological Society.